Studies using dual-energy X-ray absorptiometry (DXA) demonstrate reductions in total fat mass up to 10.9 kg, with particular effectiveness in reducing visceral fatthe metabolically harmful abdominal fat strongly associated with cardiovascular and metabolic disease risk
Semaglutide GLP-1 (Wegovy): Semaglutide GLP-1 is available as a weekly injectable option that many patients find convenient
It is generally harmless and temporary but can be annoying and disruptive
This can take up to 30 days, and sometimes they'll come back requesting more information
UK SmPCs for licensed GLP-1 receptor agonists advise counselling patients on the symptoms of thyroid tumours
You have them in your brain (hypothalamus, brainstem), pancreas (beta cells and alpha cells), stomach, intestines, heart, and kidneys